Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Emerging Themes in Epidemiology
Published in: Emerging Themes in Epidemiology 1/2013

Open Access 01-12-2013 | Analytic perspective

Trends in parameterization, economics and host behaviour in influenza pandemic modelling: a review and reporting protocol

Authors: Luis R Carrasco, Mark Jit, Mark I Chen, Vernon J Lee, George J Milne, Alex R Cook

Published in: Emerging Themes in Epidemiology | Issue 1/2013

Login to get access

Abstract

Background

The volume of influenza pandemic modelling studies has increased dramatically in the last decade. Many models incorporate now sophisticated parameterization and validation techniques, economic analyses and the behaviour of individuals.

Methods

We reviewed trends in these aspects in models for influenza pandemic preparedness that aimed to generate policy insights for epidemic management and were published from 2000 to September 2011, i.e. before and after the 2009 pandemic.

Results

We find that many influenza pandemics models rely on parameters from previous modelling studies, models are rarely validated using observed data and are seldom applied to low-income countries. Mechanisms for international data sharing would be necessary to facilitate a wider adoption of model validation. The variety of modelling decisions makes it difficult to compare and evaluate models systematically.

Conclusions

We propose a model Characteristics, Construction, Parameterization and Validation aspects protocol (CCPV protocol) to contribute to the systematisation of the reporting of models with an emphasis on the incorporation of economic aspects and host behaviour. Model reporting, as already exists in many other fields of modelling, would increase confidence in model results, and transparency in their assessment and comparison.
Appendix
Available only for authorised users
Literature
1.
Mills C, Robins J, Lipsitch M: Transmissibility of 1918 pandemic influenza. Nature. 2004, 432: 904-906.CrossRefPubMed
2.
3.
Fraser C, Donnelly C, Cauchemez S, Hanage W, Van Kerkhove M, Hollingsworth T, Griffin J, Baggaley R, Jenkins H, Lyons E, et al: Pandemic potential of a strain of influenza A (H1N1): early findings. Science. 2009, 324: 1557-1561.PubMedCentralCrossRefPubMed
4.
Cauchemez S, Valleron A, Boelle P, Flahault A, Ferguson N: Estimating the impact of school closure on influenza transmission from Sentinel data. Nature. 2008, 452: 750-754.CrossRefPubMed
5.
Ferguson N, Cummings D, Cauchemez S, Fraser C, Riley S, Aronrag M, Iamsirithaworn S, Burke D: Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 2005, 437: 209-214.CrossRefPubMed
6.
Brown ST, Tai JHY, Bailey RR, Cooley PC, Wheaton WD, Potter MA, Voorhees RE, LeJeune M, Grefenstette JJ, Burke DS, et al: Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost?: a computational simulation of Pennsylvania. BMC Publ Health. 2011, 11: 353.CrossRef
7.
Andradottir S, Chiu W, Goldsman D, Lee M, Tsui K-L, Sander B, Fisman D, Nizam A: Reactive strategies for containing developing outbreaks of pandemic influenza. BMC Publ Health. 2011, 11: S1.CrossRef
8.
Anderson RM, May RM: Infectious Diseases of Humans: Dynamics & Control. New York, USA: Oxford University Press; 1992.
9.
Baguelin M, Hoek AJV, Jit M, Flasche S, White PJ, Edmunds WJ: Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. Vaccine. 2010, 28: 2370-2384.CrossRefPubMed
10.
Fenichel EP, Castillo-Chavez C, Ceddia MG, Chowell G, Parra PAG, Hickling GJ, Holloway G, Horan R, Morin B, Perrings C, et al: Adaptive human behavior in epidemiological models. Proc Natl Acad Sci U S A. 2011, 108: 6306-6311.PubMedCentralCrossRefPubMed
11.
12.
Bajardi P, Poletto C, Ramasco JJ, Tizzoni M, Colizza V, Vespignani A: Human mobility networks, travel restrictions, and the global spread of 2009 H1N1 pandemic. PLoS One. 2011, 6: e16591.PubMedCentralCrossRefPubMed
13.
Yu H, Cauchemez S, Donnelly CA, Zhou L, Feng L, Xiang N, Zheng J, Ye M, Huai Y, Liao Q: Transmission dynamics, border entry screening, and school holidays during the 2009 influenza A (H1N1) pandemic, China. Emerg Infect Dis. 2012, 18: 758.PubMedCentralCrossRefPubMed
14.
Lee VJ, Yap J, Cook AR, Chen MI, Tay JK, Tan BH, Loh JP, Chew SW, Koh WH, Lin R, et al: Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks. N Engl J Med. 2010, 2010 (362): 2166-2174.CrossRef
15.
Daley DJ, Gani J: Epidemic Modelling: An Introduction. Page 13. Cambridge: Cambridge University Press; 2001.
16.
Keeling MJ, Rohani P: Modeling Infectious Diseases in Humans and Animals. Page 10. Princeton Univ Press: Princeton; 2007.
17.
Sargent RG: Verification and validation of simulation models. Proceedings of the 2005 Winter Simulation Conference. Edited by: Kuhl ME, Steiger NM, Armstrong FB, Joines JA. Piscataway, New Jersey, USA; 2005, 130-143.CrossRef
18.
Kermack WO, McKendrick AG: A contribution to the mathematical theory of infections. Proc R Soc Lond A. 1927, 115: 700-721.CrossRef
19.
Gumel A, Ruan S, Day T, Watmough J, Brauer F, van den Driessche P, Gabrielson D, Bowman C, Alexander M, Ardal A, et al: Modelling strategies for controlling SARS outbreaks. Proc R Soc B. 2004, 271: 2223-2232.PubMedCentralCrossRefPubMed
20.
21.
Riley S: Large-scale spatial-transmission models of infectious disease. Science. 2007, 316: 1298-1301.CrossRefPubMed
22.
23.
Arino J, Bauch CT, Brauer F, Driedger SM, Greer AL, Moghadas SM, Pizzi NJ, Sander B, Tuite A, van den Driessche P, et al: Pandemic influenza: modelling and public health perspectives. Math Biosci Eng. 2011, 8: 1-20.CrossRefPubMed
24.
Grassly NC, Fraser C: Mathematical models of infectious disease transmission. Nat Rev Microbiol. 2008, 6: 477-487.PubMed
25.
Lee V, Lye D, Wilder-Smith A: Combination strategies for pandemic influenza response—a systematic review of mathematical modeling studies. BMC Med. 2009, 7: 76.PubMedCentralCrossRefPubMed
26.
Pérez Velasco R, Praditsitthikorn N, Wichmann K, Mohara A, Kotirum S, Tantivess S, Vallenas C, Harmanci H, Teerawattananon Y: Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics. PLoS One. 2012, 7: e30333.PubMedCentralCrossRefPubMed
27.
Funk S, Salathe M, Jansen VAA: Modelling the influence of human behaviour on the spread of infectious diseases: a review. J R Soc Interface. 2010, 7: 1247-1256.PubMedCentralCrossRefPubMed
28.
Moher D, Liberati A, Tetzlaff J, Altman DG, The PG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6: e1000097.PubMedCentralCrossRefPubMed
29.
Grüne-Yanoff T, Weirich P: The philosophy and epistemology of simulation: a review. Simul Gaming. 2010, 41: 20-50.CrossRef
30.
Winsberg E: Models of success versus the success of models: reliability without truth. Synthese. 2006, 152: 1-19.CrossRef
31.
Grimm V, Berger U, Bastiansen F, Eliassen S, Ginot V, Giske J, Goss-Custard J, Grand T, Heinz SK, Huse G, et al: A standard protocol for describing individual-based and agent-based models. Ecol Model. 2006, 198: 115-126.CrossRef
32.
33.
Milne G, Kelso J, Kelly H, Huband S, McVernon J: A small community model for the transmission of infectious diseases: comparison of school closure as an intervention in individual-based models of an influenza pandemic. PLoS One. 2008, 3: e4005.PubMedCentralCrossRefPubMed
34.
Glass K, Barnes B: How much would closing schools reduce transmission during an influenza pandemic?. Epidemiology. 2007, 18: 623-628.CrossRefPubMed
35.
House T, Baguelin M, Van Hoek AJ, White PJ, Sadique Z, Eames K, Read JM, Hens N, Melegaro A, Edmunds WJ, Keeling MJ: Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic. Proc R Soc B Biol Sci. 2011, 278: 2753-2760.CrossRef
36.
Vynnycky E, Edmunds W: Analyses of the 1957 (Asian) influenza pandemic in the United Kingdom and the impact of school closures. Epidemiol Infect. 2008, 136: 166-179.PubMedCentralPubMed
37.
38.
Lee VJ, Chen MI: Effectiveness of neuraminidase inhibitors for preventing staff absenteeism during pandemic influenza. Emerg Infect Dis. 2007, 13: 449-457.PubMedCentralCrossRefPubMed
39.
Lee S, Chowell G, Castillo-Chávez C: Optimal control for pandemic influenza: the role of limited antiviral treatment and isolation. J Theor Biol. 2010, 265: 136-150.CrossRefPubMed
40.
Cooley P, Lee BY, Brown S, Cajka J, Chasteen B, Ganapathi L, Stark JH, Wheaton WD, Wagener DK, Burke DS: Protecting health care workers: a pandemic simulation based on Allegheny County. Influenza Other Respir Viruses. 2010, 4: 61-72.PubMedCentralCrossRefPubMed
41.
Chao DL, Halloran ME, Obenchain VJ, Longini IM Jr: FluTE, a publicly available stochastic influenza epidemic simulation model. PLoS Comput Biol. 2010, 6: e1000656.PubMedCentralCrossRefPubMed
42.
Savachkin A, Uribe A: Dynamic redistribution of mitigation resources during influenza pandemics. Socio Econ Plan Sci. In Press.
43.
Ong JBS, Chen MI, Cook AR, Lee HC, Lee VJ, Lin RTP, Tambyah PA, Goh LG: Real-time epidemic monitoring and forecasting of H1N1-2009 using influenza-like illness from general practice and family doctor clinics in Singapore. PLoS One. 2010, 5: e10036.PubMedCentralCrossRefPubMed
44.
Galvani A, Reluga T, Chapman G: Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proc Natl Acad Sci U S A. 2007, 104: 5692-5697.PubMedCentralCrossRefPubMed
45.
46.
Mylius SD, Hagenaars TJ, Lugner AK, Wallinga J: Optimal allocation of pandemic influenza vaccine depends on age, risk and timing. Vaccine. 2008, 26: 3742-3749.CrossRefPubMed
47.
Tuite AR, Fisman DN, Kwong JC, Greer AL: Optimal pandemic influenza vaccine allocation strategies for the Canadian population. PLoS One. 2010, 5: e10520.PubMedCentralCrossRefPubMed
48.
Krumkamp R, Kretzschmar M, Rudge JW, Ahmad A, Hanvoravongchai P, Westenhoefer J, Stein M, Putthasri W, Coker R: Health service resource needs for pandemic influenza in developing countries: a linked transmission dynamics, interventions and resource demand model. Epidemiol Infect. 2011, 139: 59-67.CrossRefPubMed
49.
50.
Halloran M, Ferguson N, Eubank S, Longini I, Cummings D, Lewis B, Xu S, Fraser C, Vullikanti A, Germann T, et al: Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A. 2008, 105: 4639-4644.PubMedCentralCrossRefPubMed
51.
Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, et al: Scalia Tomba G, Wallinga J, et al: Social contacts and mixing patterns relevant to the spread of infectious diseases. Plos Med. 2008, 5: 381-391.CrossRef
52.
Lee PM: Bayesian Statistics: An Introduction. 3rd edition. London: Arnold; 2004.
53.
Thomas A: O Hara B, Ligges U, Sturtz S: Making BUGS open. R News. 2006, 6: 12-17.
54.
Plummer M: JAGS: a program for analysis of Bayesian graphical models using Gibbs sampling. Proceedings of the 3rd International Workshop on Distributed Statistical Computing (DSC 2003), March 20-22. Edited by: Hornik K, Leisch F, Zeileis A. Vienna, Austria: Technische Universität Wien; 2003, ISSN 1609-395X 2003.
55.
Doucet A, Godsill S, Andrieu C: On sequential Monte Carlo sampling methods for Bayesian filtering. Stat Comput. 2000, 10: 197-208.CrossRef
56.
57.
Colizza V, Barrat A, Barthelemy M, Valleron A, Vespignani A: Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions. PLoS Med. 2007, 4: e13.PubMedCentralCrossRefPubMed
58.
Debarre F, Bonhoeffer S, Regoes R: The effect of population structure on the emergence of drug-resistance during pandemic influenza. J R Soc Interface. 2007, 4: 893-906.PubMedCentralCrossRefPubMed
59.
Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, Doumbo OK, Greenwood B, Hall BF, Levine MM, et al: A research agenda to underpin malaria eradication. PLoS Med. 2011, 8: e1000406.PubMedCentralCrossRefPubMed
60.
Drummond MF, Barbieri M, Wong J: Analytic choices in economic models of treatments for rheumatoid arthritis: what makes a difference?. Med Dec Making. 2005, 25: 520-533.CrossRef
61.
Eaton JW, Johnson LF, Salomon JA, Bärnighausen T, Bendavid E, Bershteyn A, Bloom DE, Cambiano V, Fraser C, Hontelez JAC, et al: HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 2012, 9: e1001245.PubMedCentralCrossRefPubMed
62.
Sargent RG: A tutorial on validation and verification of simulation models. 1988 Winter Simulation Conference. San Diego, USA; 1988.
63.
Lugnér AK, Mylius SD, Wallinga J: Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic. Heal Econ. 2009, 19: 518-531.
64.
Ferguson N, Cummings D, Fraser C, Cajka J, Cooley P, Burke D: Strategies for mitigating an influenza pandemic. Nature. 2006, 442: 448-452.CrossRefPubMed
65.
Germann T, Kadau K, Longini I, Macken C: Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci U S A. 2006, 103: 5935-5940.PubMedCentralCrossRefPubMed
66.
Keogh-Brown MR, Smith RD, Edmunds JW, Beutels P: The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands. Eur J Heal Econ. 2010, 11: 543-554.CrossRef
67.
68.
Jung E, Iwami S, Takeuchi Y, Jo T-C: Optimal control strategy for prevention of avian influenza pandemic. J Theor Biol. 2009, 260: 220-229.CrossRefPubMed
69.
70.
Tanner MW, Sattenspiel L, Ntaimo L: Finding optimal vaccination strategies under parameter uncertainty using stochastic programming. Math Biosci. 2008, 215: 144-151.CrossRefPubMed
71.
Prosper O, Saucedo O, Thompson D, Torres-Garcia G, Wang XH, Castillo-Chavez C: Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza. Math Biosci Eng. 2011, 8: 141-170.CrossRefPubMed
72.
Khazeni N, Hutton DW, Garber AM, Owens DK: Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic. Ann Intern Med. 2009, 151: 840-853.PubMedCentralCrossRefPubMed
73.
Carrasco LR, Lee VJ, Chen MI, Matchar DB, Thompson JP, Cook AR: Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective. J R Soc Interface. 2011, 8: 1307-1313.PubMedCentralCrossRefPubMed
74.
Barrett C, Bisset K, Leidig J, Marathe A, Marathe M: Economic and social impact of influenza mitigation strategies by demographic class. Epidemics. 2011, 3: 19-31.PubMedCentralCrossRefPubMed
75.
Lee BY, Brown ST, Korch GW, Cooley PC, Zimmerman RK, Wheaton WD, Zimmer SM, Grefenstette JJ, Bailey RR, Assi T-M, Burke DS: A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic. Vaccine. 2010, 28: 4875-4879.PubMedCentralCrossRefPubMed
76.
Epstein J, Goedecke D, Yu F, Morris R, Wagener D, Bobashev G: Controlling pandemic flu: the value of international air travel restrictions. PLoS One. 2007, 2: e401.PubMedCentralCrossRefPubMed
77.
Sander B, Nizam A, Garrison L, Postma M, Halloran M, Longini I: Economic evaluation of influenza pandemic mitigation strategies in the US using a stochastic microsimulation transmission model. Value Health. 2008, 12: 226-233.PubMedCentralCrossRefPubMed
78.
Dixon PB, Lee B, Muehlenbeck T, Rimmer MT, Rose A, Verikios G: Effects on the U.S. of an H1N1 epidemic: analysis with a quarterly CGE model. J Homel Secur Emerg Manag. 2010, 7: article75.
79.
Smith RD, Keogh-Brown MR, Barnett T: Estimating the economic impact of pandemic influenza: an application of the computable general equilibrium model to the UK. Soc Sci Med. 2011, 73: 235-244.CrossRefPubMed
80.
Shim E, Meyers LA, Galvani AP: Optimal H1N1 vaccination strategies based on self-interest versus group interest. BMC Publ Health. 2011, 11 (Suppl 1): S4.CrossRef
81.
82.
Morimoto T, Ishikawa H: Assessment of intervention strategies against a novel influenza epidemic using an individual-based model. Environ Health Prev Med. 2010, 15: 151-161.PubMedCentralCrossRefPubMed
83.
Aleman DM, Wibisono TG, Schwartz B: A nonhomogeneous agent-based simulation approach to modeling the spread of disease in a pandemic outbreak. Interfaces. 2011, 41: 301-315.CrossRef
84.
Kelso J, Milne G, Kelly H: Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza. BMC Publ Health. 2009, 9: 117.CrossRef
85.
Loganathan P, Sundaramoorthy S, Lakshminarayanan S: Modeling information feedback during H1N1 outbreak using stochastic agent-based models. Asia Pac J Chem Eng. 2011, 6: 391-397.CrossRef
86.
Lau J, Yang X, Pang E, Tsui H, Wong E, Wing Y: SARS-related perceptions in Hong Kong. Emerg Infect Dis. 2005, 11: 417-424.PubMedCentralPubMed
87.
Jørgensen SE, Fath BD, Grant W, Nielsen SN: The editorial policy of ecological modelling. Ecol Model. 2006, 199: 1-3.CrossRef
88.
Grimm V, Berger U, DeAngelis DL, Polhill JG, Giske J, Railsback SF: The ODD protocol: a review and first update. Ecol Model. 2010, 221: 2760-2768.CrossRef
89.
Birch S, Gafni A: On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales. Heal Econ. 2002, 11: 185-191.CrossRef
90.
91.
Murray C, Evans DB, Acharya A, Baltussen R: Development of WHO guidelines on generalized cost-effectiveness analysis. Heal Econ. 2000, 9: 235-251.CrossRef
92.
Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR: Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices—Modeling Studies. Value Health. 2003, 6: 9-17.CrossRefPubMed
Metadata
Title
Trends in parameterization, economics and host behaviour in influenza pandemic modelling: a review and reporting protocol
Authors
Luis R Carrasco
Mark Jit
Mark I Chen
Vernon J Lee
George J Milne
Alex R Cook
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Emerging Themes in Epidemiology / Issue 1/2013
Electronic ISSN: 1742-7622
DOI
https://doi.org/10.1186/1742-7622-10-3

Other articles of this Issue 1/2013

Emerging Themes in Epidemiology 1/2013 Go to the issue

Analytic perspective

Estimating HIV prevalence from surveys with low individual consent rates: annealing individual and pooled samples

Analytic perspective

Data harmonization and federated analysis of population-based studies: the BioSHaRE project

Analytic perspective

Four issues in undernutrition-related health impact modeling

Methodology

Why is greater medication adherence associated with better outcomes

Methodology

Log-binomial models: exploring failed convergence

Methodology

The effect of clustering on lot quality assurance sampling: a probabilistic model to calculate sample sizes for quality assessments